Our in vivo studies, revealing ThA's effect via AMPK and Nrf2 pathways, reinforce the complexity of ferroptosis regulation and the need for targeted therapeutic strategies to combat neurodegenerative diseases effectively. The gene discussed is NFE2L2; the disease is neurodegenerative disease.